167 related articles for article (PubMed ID: 32733244)
1. O-1602, an Agonist of Atypical Cannabinoid Receptors GPR55, Reverses the Symptoms of Depression and Detrusor Overactivity in Rats Subjected to Corticosterone Treatment.
Wróbel A; Serefko A; Szopa A; Ulrich D; Poleszak E; Rechberger T
Front Pharmacol; 2020; 11():1002. PubMed ID: 32733244
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of atypical cannabinoid receptor GPR55 abolishes the symptoms of detrusor overactivity in spontaneously hypertensive rats.
Wróbel A; Serefko A; Szopa A; Poleszak E
Eur J Pharm Sci; 2020 Jul; 150():105329. PubMed ID: 32360768
[TBL] [Abstract][Full Text] [Related]
3. A Novel Alternative in the Treatment of Detrusor Overactivity? In Vivo Activity of O-1602, the Newly Synthesized Agonist of GPR55 and GPR18 Cannabinoid Receptors.
Wróbel A; Szopa A; Serefko A; Poleszak E
Molecules; 2020 Mar; 25(6):. PubMed ID: 32197469
[TBL] [Abstract][Full Text] [Related]
4. The Cannabinoid Ligand Arachidonyl-2'-Chloroethylamide (ACEA) Ameliorates Depressive and Overactive Bladder Symptoms in a Corticosterone-Induced Female Wistar Rat Model.
Zapała Ł; Niemczyk G; Zapała P; Wdowiak A; Bojar I; Kluz T; Szopa A; Serefko A; Radziszewski P; Wróbel A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835228
[TBL] [Abstract][Full Text] [Related]
5. The effect of O-1602, a GPR55 agonist, on the cyclophosphamide-induced rat hemorrhagic cystitis.
Wróbel A; Zapała Ł; Zapała P; Piecha T; Radziszewski P
Eur J Pharmacol; 2020 Sep; 882():173321. PubMed ID: 32615180
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Rho kinase by GSK 269962 reverses both corticosterone-induced detrusor overactivity and depression-like behaviour in rats.
Wróbel A; Serefko A; Rechberger E; Banczerowska-Górska M; Poleszak E; Dudka J; Skorupska K; Miotła P; Semczuk A; Kulik-Rechberger B; Mandziuk S; Rechberger T
Eur J Pharmacol; 2018 Oct; 837():127-136. PubMed ID: 30172788
[TBL] [Abstract][Full Text] [Related]
7. Blebbistatin, a Myosin II Inhibitor, Exerts Antidepressant-Like Activity and Suppresses Detrusor Overactivity in an Animal Model of Depression Coexisting with Overactive Bladder.
Wróbel A; Doboszewska U; Rechberger E; Bańczerowska-Górska M; Czuczwar P; Poleszak E; Dudka J; Wlaź P; Miotła P; Wlaźlak E; Rechberger T
Neurotox Res; 2019 Jan; 35(1):196-207. PubMed ID: 30155683
[TBL] [Abstract][Full Text] [Related]
8. The influence of duloxetine on detrusor overactivity in rats with depression induced by 13-cis-retinoic acid.
Wróbel A; Rechberger E; Rechberger T
Int Urogynecol J; 2018 Jul; 29(7):987-995. PubMed ID: 28762178
[TBL] [Abstract][Full Text] [Related]
9. Asiatic Acid, a Natural Compound that Exerts Beneficial Effects on the Cystometric and Biochemical Parameters in the Retinyl Acetate-Induced Model of Detrusor Overactivity.
Wróbel A; Serefko A; Szopa A; Poleszak E
Front Pharmacol; 2020; 11():574108. PubMed ID: 33584259
[TBL] [Abstract][Full Text] [Related]
10. Fourteen-day administration of corticosterone may induce detrusor overactivity symptoms.
Wróbel A; Serefko A; Poleszak E; Rechberger T
Int Urogynecol J; 2016 Nov; 27(11):1713-1721. PubMed ID: 27142032
[TBL] [Abstract][Full Text] [Related]
11. Alterations in Gene and Protein Expression of Cannabinoid CB
García-Gutiérrez MS; Navarrete F; Navarro G; Reyes-Resina I; Franco R; Lanciego JL; Giner S; Manzanares J
Neurotherapeutics; 2018 Jul; 15(3):796-806. PubMed ID: 29435814
[TBL] [Abstract][Full Text] [Related]
12. An animal model of detrusor overactivity induced by depression.
Wróbel A; Rechberger T
J Pharmacol Toxicol Methods; 2016; 80():19-25. PubMed ID: 27050558
[TBL] [Abstract][Full Text] [Related]
13. SN003, a CRF
Wróbel A; Doboszewska U; Rechberger E; Wlaź P; Rechberger T
Eur J Pharmacol; 2017 Oct; 812():216-224. PubMed ID: 28705713
[TBL] [Abstract][Full Text] [Related]
14. The role of the peripheral cannabinoid system in the pathogenesis of detrusor overactivity evoked by increased intravesical osmolarity in rats.
Juszczak K; Maciukiewicz P
Can J Physiol Pharmacol; 2015 Aug; 93(8):721-6. PubMed ID: 26243021
[TBL] [Abstract][Full Text] [Related]
15. The neuroprotective effects of GPR55 against hippocampal neuroinflammation and impaired adult neurogenesis in CSDS mice.
Shen SY; Yu R; Li W; Liang LF; Han QQ; Huang HJ; Li B; Xu SF; Wu GC; Zhang YQ; Yu J
Neurobiol Dis; 2022 Jul; 169():105743. PubMed ID: 35490927
[TBL] [Abstract][Full Text] [Related]
16. Expression of cannabinoid 1 and, 2 receptors and the effects of cannabinoid 1 and, 2 receptor agonists on detrusor overactivity associated with bladder outlet obstruction in rats.
Kim SD; Cho KJ; Kim JC
BMC Urol; 2017 Dec; 17(1):121. PubMed ID: 29284441
[TBL] [Abstract][Full Text] [Related]
17. Activation of GPR55 induces neuroprotection of hippocampal neurogenesis and immune responses of neural stem cells following chronic, systemic inflammation.
Hill JD; Zuluaga-Ramirez V; Gajghate S; Winfield M; Sriram U; Rom S; Persidsky Y
Brain Behav Immun; 2019 Feb; 76():165-181. PubMed ID: 30465881
[TBL] [Abstract][Full Text] [Related]
18. Central administration of GPR55 receptor agonist and antagonist modulates anxiety-related behaviors in rats.
Rahimi A; Hajizadeh Moghaddam A; Roohbakhsh A
Fundam Clin Pharmacol; 2015 Apr; 29(2):185-90. PubMed ID: 25620584
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptor expression in the bladder is altered in detrusor overactivity.
Bakali E; McDonald J; Elliott RA; Lambert DG; Tincello DG
Int Urogynecol J; 2016 Jan; 27(1):129-39. PubMed ID: 26224382
[TBL] [Abstract][Full Text] [Related]
20. The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55.
Schuelert N; McDougall JJ
Neurosci Lett; 2011 Aug; 500(1):72-6. PubMed ID: 21683763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
